Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Dedifferentiated Liposarcoma”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Early research (Phase 1)Looking for participantsNCT05607095
What this trial is testing

LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

Who this might be right for
Uveal MelanomaMelanomaMetastatic Uveal Melanoma+1 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05886634
What this trial is testing

Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Who this might be right for
Dedifferentiated LiposarcomaSoft Tissue SarcomaSarcoma,Soft Tissue+4 more
Memorial Sloan Kettering Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT05218499
What this trial is testing

Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

Who this might be right for
Liposarcoma, Dedifferentiated
Boehringer Ingelheim 400
Early research (Phase 1)Ended earlyNCT03604783
What this trial is testing

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsSarcomaEwing Sarcoma+2 more
Sumitomo Pharma America, Inc. 74
Large-scale testing (Phase 3)Study completedNCT06058793
What this trial is testing

Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

Who this might be right for
Liposarcoma, Dedifferentiated
Boehringer Ingelheim 138
Large-scale testing (Phase 3)Active Not RecruitingNCT04967521
What this trial is testing

SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma

Who this might be right for
Advanced Dedifferentiated Liposarcoma
Sarcoma Alliance for Research through Collaboration 108
Testing effectiveness (Phase 2)WithdrawnNCT00969917
What this trial is testing

Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
Infinity Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT02606461
What this trial is testing

Selinexor in Advanced Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
Karyopharm Therapeutics Inc 342
Early research (Phase 1)Study completedNCT04242238
What this trial is testing

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Who this might be right for
SarcomaAdvanced SarcomaHigh Grade Sarcoma+4 more
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT06843967
What this trial is testing

Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Who this might be right for
Well Differentiated LiposarcomaDedifferentiated LiposarcomaLiposarcoma+6 more
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)UnknownNCT02571829
What this trial is testing

A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Who this might be right for
LiposarcomaSoft Tissue Sarcoma
Hadassah Medical Organization 30
Testing effectiveness (Phase 2)UnknownNCT03096912
What this trial is testing

A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Who this might be right for
Liposarcomas, DedifferentiatedLiposarcoma - Well DifferentiatedLiposarcoma; Mixed Type+1 more
Assaf-Harofeh Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT02500797
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Who this might be right for
Locally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more
National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Study completedNCT02247544
What this trial is testing

Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma

Who this might be right for
LiposarcomaLeiomyosarcoma
Italian Sarcoma Group 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694871
What this trial is testing

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Who this might be right for
Advanced Dedifferentiated LiposarcomaLocally Advanced Dedifferentiated LiposarcomaMetastatic Dedifferentiated Liposarcoma+3 more
Alliance for Clinical Trials in Oncology 77
Testing effectiveness (Phase 2)Ended earlyNCT01876043
What this trial is testing

Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial

Who this might be right for
Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma
Institut Bergonié 24
Testing effectiveness (Phase 2)Ended earlyNCT05116683
What this trial is testing

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma

Who this might be right for
LeiomyosarcomaLiposarcoma
Benjamin Izar 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT03114527
What this trial is testing

Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

Who this might be right for
Soft Tissue Sarcoma
Fox Chase Cancer Center 48
Testing effectiveness (Phase 2)Ended earlyNCT05580588
What this trial is testing

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

Who this might be right for
Liposarcoma, Dedifferentiated
Shanghai Pharma Biotherapeutics USA Inc. 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06694324
What this trial is testing

First-line Treatment of Advanced/unresectable DDLPS

Who this might be right for
Dedifferentiated LiposarcomaSoft Tissue Sarcoma (STS)
Fudan University 49
Load More Results